INTERNATIONAL PATENT: NEWAMSTERDAM PHARMA B.V., FILES APPLICATION FOR "OBICETRAPIB FOR THE TREATMENT OF DEMENTIAS"

GENEVA, March 30 -- NEWAMSTERDAM PHARMA B.V., (Gooimeer 2-351411 DC Naarden) filed a patent application (PCT/EP2025/076526) for "OBICETRAPIB FOR THE TREATMENT OF DEMENTIAS" on Sep 17, 2025. With publication no. WO/2026/062049, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DAVIDSON, Michael Harvey (Gooimeer 2-351411 DC Naarden), KASTELEIN, Johannes Jacob Pieter (Gooimeer 2-351411 DC Naarden), DITMARSCH, Marc (Gooimeer 2-351411 DC Naarden)

Abstract: Methods are also presented for favorably affecting biomarkers involved w...